Stocks in play: Tryp Therapeutics Inc
Announced a non-brokered private placement to its co-Founder and Executive Director, William J. Garner, M.D. The Placement consists of 11,111,111 million units at a price of $0.18 per Unit, to raise gross proceeds of approximately $2.0 million. Each Unit consists of one Common Share and one Common Share purchase warrant. Each Warrant entitles the holder to acquire one additional Common Share at a price of $0.25 per Common Share for a period of 24 months from the date of issuance. Tryp Therapeutics Inc shares C.TRYP are trading down $0.04 at $0.16.
Read:
Optimism on the Rise Thanks to New Developments in Oncology in the Fight Against Cancer
Double-Digit Growth in Global Cancer Immunotherapy Market to Drive Advancements Ahead of 2030
Wave of Massive ESG Investments Triggering Major Developments in Mining of Critical Minerals
Investment in New Plant-Based Alternative Meat Products Ramps Up Into 2022
New Treatments Needed as Breast Cancer Was Leading Killer of Female Cancer Patients in 2019